Loading
Every time a team of specialists meets to plan a patient's treatment, they would have to record whether a trial exists for that patient and, if so, why it was or was not offered.
Multidisciplinary tumour boards and molecular tumour boards add a required structured field to their recommendation: matched trials considered (with identifiers), offered yes/no, and reason if not. A trial coordinator pre-populates the field from a matching tool before the meeting. The field is auditable and the offer rate reported quarterly by service.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares Trials enrol too few, too slowly, Memorial Sloan Kettering Cancer Center.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/